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ABSTRACT
This research was part of a multidisciplinary effort aimed at the elucidation
of the mechanism of membrane lysis by model peptides. The focus of the
dissertation was to characterize the average size dimensions of model cell
membranes before and after being treated by model peptides. Experiments
with neutral dioleoylphosphatidylcholine (DOPC) vesicles and negatively
charged dioleoylphosphatidylcholine/dioleoylphosphatidylglycerol
(DOPC/DOPG) vesicles were conducted using the model peptides
(KLAKKLA)3 and (KLGKKLGfe. A melittin study was conducted alongside for
comparison. Changes in membrane integrity were studied as a function of
lipid-to-peptide (L:P) ratio using three techniques: kinetic light scattering
(KLS), dynamic light scattering (DLS), and fluorescence photobleaching and
recovery (FPR).
The document is divided into four chapters. The first chapter gives a
general introduction. The second chapter introduces the KLS concept along
with latex calibrations and preliminary measurements of surfactant/vesicle
interactions. In chapter 3 the interaction between neutral and negatively
charged vesicles composed of dioleoylphosphatidylcholine (DOPC) and
dioleoylphosphatidylglycerol with the model peptides (KLAKKLA)3 and
(KLGKKLG)3 is examined as a function of lipid-to-peptide ratio. Chapter 4
outlines a complement FPR study to chapter 3. Also presented in this
chapter are results from experiments of the same lipid systems with melittin.

XV

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER 1
INTRODUCTION

1
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1.1 LYTIC PEPTIDES
1.1.1 Definition and Amphipathic Character
The interaction of lytic peptides with model cell membranes has posed a
long-standing challenge to the area of biophysical research. The term “lytic”
refers to the peptide’s ability to disrupt/restructure cell membranes. In
nature lytic peptides play a key role in the defense systems of many animal
species such as insects, amphibians, and mammals. Isolation, purification,
and characterization from their biological sources have led to the discovery
of several distinct classes of lytic peptides. The more studied types include
cecropins, defensins, and magainins.1'3 In part, the potent antimicrobial
properties of lytic peptides have been attributed to their amphipathic ahelical character. The amphipathic a-helix is defined as an a-helical region
of a protein in which the amino acid residues are distributed in the
secondary structure to form opposing polar and nonpolar faces.4 The
amphipathic a-helix was first recognized in myoglobin in 1965.5 In 1969, it
was postulated that an amphipathic a-helical structure might account for
lipid-protein interactions in the apolipoproteins of plasma lipoproteins.6 The
amphipathic a-helix has been proposed as an important structural feature of
several peptide hormones and cytotoxic peptides.7 To conclude their
studies Kaiser & Kezdy reported that “membrane affinity is determined by
the ability of the peptide to assume an amphiphilic structure” and “the
amphiphilicity of the peptide is defined by its secondary structure”.8 Other
properties that are reported to help account for the antimicrobial activity of
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lytic peptides include net cationic charges and relatively short lengths. The
importance of charge is demonstrated by the preferential binding of
antimicrobial peptides to bacteria which are negatively charged over
mammalian cells which are neutral in charge.9 Peptide lengths of 23-29
amino acid residues are typical. Lear proposed in 1988 that a length of 20
residues was necessary for effective lytic activity through ion channel
formation.10 This number was modified in 1991 when peptides of 8-12
amino acid residues were also shown to display lytic activity via ion
channels.11
Of all the naturally occurring lytic peptides, melittin is probably the most
widely studied.12'16 It is the principle toxin in bee venom and possesses
both powerful antimicrobial and cytolytic properties.17 Several mechanisms
propose to account for its activity but none has been successfully proven.
Among the more widely reported mechanisms are membrane micellization,
ion channel formation, and wedge-shaped insertion into the membrane to
induce cytolysis.18'20

1.1.2 Model Amphipathic a-Helical Peptides
Antibiotics continue to be used as primary agents against infectious
diseases. The subsequent production of antibiotic-resistant "super bugs”
has created the need for newer, more potent disease-fighting alternatives.
Lytic peptides have become drug prototypes for the design and synthesis of
new peptide analog varieties that promise comparable and better limits of
activity.21 The rational design of model amphipathic a-helical peptides

3
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(MAPS) not only addresses this need but additionally aids fundamental
investigations of the structure/function relationships in peptide/membrane
interactions.22 Systematically varying the residues of the parent species to
probe the effects of charge distribution, modifying the size/shape of the
hydrophobic region of the peptide, and adjusting peptide length usually
dominate the approach of design strategies. Pioneering work in this area
has been performed by many authors.23'26 It is the main thrust of this
manuscript to focus on the characterization of the membrane interactions of
two model peptide analogs with high antimicrobial activity and low
mammalian cell toxicity, (KLAKKLA)3 and (KLGKKLG)3. A collaborating
group carried out their design and synthesis. Details of their design,
synthesis, and characterization can be read elsewhere.27'28
1.2 MODEL CELL MEMBRANES
1.2.1 Defining Characteristics
Liposomes have evolved tremendously as models for the study of
biological membrane structure and function.29130 Liposomes are vesicles in
which an aqueous volume is entirely enclosed by a membrane composed of
lipid molecules. Phosphatidylcholine molecules are the most common lipids
and are used extensively as the principal phospholipid in liposomes
because of their low cost, neutral charge, and chemical inertness.31 They
were first observed in 1947 by Bernard in his studies of myelin figures
formed by ammonium oleate.32 It was later in 1962, when electron
microscope images of phospholipid dispersions in water were observed by

4
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Bangham and Horne, that their existence was verified and the new
structures were first given the name “liposomes”.33 The value of liposomes
as model membrane systems derives from the fact that liposomes can be
constructed from natural constituents such that they resemble biological
cells. As a result they can be used to study many cellular processes,
particularly transport/delivery phenomena. The application of liposomes as
delivery systems includes the delivery of enzymes, anticancer drugs,
fungicides, antiparasite drugs, anti-bacterials, and antiviral drugs.34-39
Liposomes have also been useful in the diagnostic imaging of tumors and
as cosmetic vehicles for the delivery of moisturizers and anti-inflammatory
agents to the skin.40141
1.2.2 Preparation and Classification
The ever-increasing market for the study and application of liposomes
has produced a strong driving force for the development of wellcharacterized and reproducible methods for their manufacture. In general,
all methods of manufacture follow a common scheme: 1) drying down of
lipids from an organic solvent stock; 2) hydration of resulting film in a buffer
solution; 3) purification/filtration of vesicles formed; and 4) analysis of the
final product.31 No matter the application, it seems that the most important
aspect of the liposome’s involvement with other molecular species is the
nature of its surface properties. The lipid surface can be manipulated by
varying the phospholipid constitution and by the addition of molecules that
modify either chemically or physically membrane integrity.42 As the

5
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formation of phospholipid membranes is a spontaneous process in aqueous
solution, most manufacturing techniques focus on customization of the final
product. The major classifications of this final product proceed according to
vesicle size and lamellar characteristics.43 Multilamellar vesicles (MLVs)
vary in size from 100-10000 nm and consist of at least five lamellae. Small
unilamellar vescles (SUV’s) range in size from 20 -5 0 nm and are defined
as liposomes at or close to their lower size limits. Large unilamellar vesicles
(LUV’s) include liposomes of diameter 1000 nm or more. Figure 1 gives a
depiction of these general classes. Other types of liposomes are defined
according to the technique of manufacture. Unilamellar vesicles of different
sizes and encapsulation volumes can be generated by a variety of
techniques either followed exclusively or in combination. Common choices
include sonication, reverse-phase evaporation (REV’S), ether injection,
detergent analysis, hand-shaking/vortexing, and extrusion.31:44 The popular
methods are especially useful for the manufacture of unilamellar vesicles of
uniform size. This is important as monodisperse populations are more
readily adaptable to theoretical principles. Liposomes used in the following
chapters were prepared using a combination of the handshaken/mechanical
dispersion method and extrusion. A complete overview of the process is
provided elsewhere.31

1.2.3 Characterization by Light Scattering
Dynamic and static light scattering have emerged as standard
techniques for characterizing liposome suspensions. The mean geometric

6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Multilamellar Vesicle
(Up to 10,000 nm)

Lipid bilayer
Aqueous
compartment

Small Unilamellar Vesicle
(20-50nm)

Large Unilamellar Vesicle
(up to iOOOnm)

Figure 1.1 Classification of vesicles (liposomes).
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size, shape, size distribution, and molecular weight can be obtained from
light scattering data. The techniques are nonperturbing, fast, and reliable.
Kolchens et al characterized the size distribution of extruded vesicles using
OLS and correlated the observed data with filter pore size, extrusion
pressure, and lipid concentration.45 For vesicles prepared by the fireezethaw extrusion method it was found that the larger the pore size of the filter,
the more dependent the vesicle size. Filter sizes used for the experiment
were 100nm, 200nm and 400nm. Lipid concentration in the range 0.1-10
mg/ml had no effect on the resulting size. Zanten et al demonstrated that
the vesicle wall thickness could be estimated using static light scattering
measurements for scatterers 40-115nm in diameter.4647 Information about
vesicle size distributions was recently extracted by Strawbridge et al using
an integrated approach to SLS with which light scattering intensity
measurements at several angles could be recorded simultaneously.48

1.3 LIGHT SCATTERING STUDIES OF PEPTIDE/MEMBRANE
INTERACTIONS
Cell membrane perturbation has been studied extensively by light
scattering techniques. In order to gain insight into the molecular
mechanisms of lysis, peptide-induced changes in the morphology of cell
membranes have been investigated by several authors.19,48'50 The most
widely studied model for peptide/membrane interactions is melittin with
mixed and/or neutral phospholipid membranes. It appears the action of
melittin restructures, by fusion or fragmentation, model membranes to form
new entities whose size and shape depend, in part, on the make-up of the

8
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lipid surface, physical state of the lipids, and the lipid-to-peptide ratio.19
Light scattering studies of melittin interacting with lipid membranes revealed
that the average size of small unilamellar phosphatidylcholine vesicles
increased upon addition of melittin up to a critical ratio of peptide to lipid
(~ 1:10) afterwhich a sharp decrease in size is observed.51 It was
hypothesized that initially melittin induced fusion of the vesicles and at some
critical lipid to peptide value micellization occurred. Neutral
phosphatidylcholine membranes were reported to be more susceptible to
micellization by melittin than phosphatidylserine membranes, which are
negatively charged. This result, in part, is due to melittin’s positive charge.
Electrostatic interactions with negatively charged membranes may keep it
on the surface of the membrane. On the other hand, interaction with a
neutral membrane allows for insertion of the peptide into the lipid bilayer
with greater ease thereby allowing leakage, reorganization, or some other
morphological change. It has also been shown that dynamic light scattering
can be used to monitor the effect of melittin on lipid bilayers of variable acyl
chain length. Faucon et al showed that the rate of disappearance of small
lipid-melittin complexes increased as the acyl chain length increased.52 In
other fundamental membrane studies, the mediation of cell fusion by
polyethylene glycol (PEG) was followed by dynamic light scattering.53 It
was determined for vesicle sizes less than 77 nm that the diameters
increased dramatically when treated with high concentrations of PEG. The
adsorption of Casein, a mixture of four proteins from milk, onto polystyrene

9
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

latices has been studied by monitoring the increase in the hydrodynamic
radius of the latex particles as protein is added.54 Integrated light scattering
spectroscopy was used to measure the swelling of POPC/POPG large
unilamellar vesicles (LUV 60:40; molimol) upon titration with the E1 colicin
channel peptide.55
1.4 REFERENCES
1

Zasloff, M. Proceedings of the National Academy of Sciences (USA)
1987, 84, 5449.

2

Boman, H.G. Cell 1999, 65, 205.

3

Ganz, T.; Selsted, M.E.; Szlarek, D.; Harwig, S.L.; Daher, K.; Bainton,
D.F.; Lehrer, R.l. Journal of Clinical Investigations 1985, 76,1427.

4

McLean, L.R.; Krstenansky, J.L.; Owen, T.J.; Hagaman, K.A.
Biochemistry 1989, 2 8 ,8403.

5

Perutz, M.F.; Kendrew, J.C.; Watson, H.C. Journal of Molecular
Biology 1965,13,669.

6

Day, C.E.; Levy, R.l. Journal of Theoretical Biology 1969, 2 3 ,387.

7

Epand, R.; Shai, Y.; Segrest, J.P.; Anantharamaiah, G.M. Biopolymers
(Peptide Science) 1995,37, 319.

8

Kaiser, E.T.; Kezdy, F.J. Annual Review of Biophysics and Biophysical
Chemistry 1987, 16,561.

9

Matsuzaki, K.; Harada, M.; Handa, T.; Munakoshi, S.; Fugii, N.;
Yajima, H.; Miyajima, K. Biochimica et Biophysics Acta 1989, 981,130.

10

Lear, J.D.; Wasserman, Z.R.; DeGrado, W.F. Science 1988, 240,
1177.

11

Anzai, K.; Hamasuna, M.; Kadono, H.; Lee, S.; Aoyagi, H.; Kirino, Y.
Biochimica etBiophysica Acta 1991,1064,256.

12

Benachir, T.; Lafleur, M. Biophysical Journal 1996, 70,831.

13

Monette, M.; Lafleur, M. Biophysical Journal 1996, 70,2195.

14

Monette, M.; Lafleur, M. Biophysical Journal 1995, 68,187.

10
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

15) Dempsey, C.E.; Bitbol, M.; Watts, A. Biochemistry 1989, 2 8 ,6590.
16) Okada, A.; Wakamatsu, K.; Miyazawa, T.; Higashijima, T. Biochemistry
1994, 33, 9438.
17) Boman, H.G.; Wade, D.; Boman, IA ; Wahlin, B.; Merrifietd, R.B. FEBS
Lett 1989,103.
18) Dawson, C.R.; Drake, A.F.; Helliwell, J.; Hider, R.C. Biochimica et
Biophysica Acta 1978, 51 0,75.
19) Dufourcq, J.; Faucon, J.F.; Fourche, G.; Dasseux, J.L.; Le Maire, M.;
Gulik-Krzywicki, T. Biochimica et Bbphysica Acta 1986, 859, 33.
20) Tosteson, M.T.; Alvarez, O.; Hubbell, W.; Bieganski, R.M.; Attenbach,
C.; Caporales, L.H.; Levy. J J-.' Nutt, R.F.; Rosenblatt, M.; Tosteson,
D.C. Biophysical Journal 1990, 5 8 ,1367.
21) Blondelle, S.E.; Houghten, R.A. Biochemistry 1992, 3 1 ,12688.
22) McLean, L.R.; Hagaman, K.A.; Owen, T.J.; Payne, M.H.; Davidson,
W.S.; Krstenansky, J.L. Biochimica et Biophysica Acta 1991, 1086,
106.
23) Lee, S.; Mihara, H.; Aoyagi, H.; Kato, T.; Izumuja, N.; Yamasaki, N.
Biochimica et Biophysica Acta 1986, 862,211.
24) Bessalle, R.; Gorea, A ; Shalit, I.; Metzger, J.W.; Dass, C.; Desiderio,
D.M.; Fridkin, M. Journal of Medicinal Chemistry 1993, 3 6 ,1203.
25) DeGrado, W.F.; Kezdy, F.J.; Kaiser, E.T. Journal of the American
Chemistry Society 1981, 103,679.
26) Andreu, D.; Ubach, J.; Boman, A ; Wahlin, B.; Wade, D.; Merrifield,
R.B.; Boman, H.G. FEBS Lett 1992,2 9 6 ,190.
27) Javadpour, M.M.; Juban, M.M.; Wai-Chun, J.L.; Bishop, S.B.; Alberty,
J.B.; Cowell, S.M.; Becker, C.L.; McLaughlin, M.L. Journal of
Medicinal Chemistry 1996, 3 9 ,3107.
28) Javadpour, M.M.; Barkley, M.D. Biochemistry 1997, 3 6 ,9540.
29) Bangham, A.D.; Standish, M.M.; Watkins, J.C. Journal of Molecular
Biology 1965,13,238.
30) Wang, C. Biochemistry 1969, 8 ,344.
31) New, R.R.C.L/posomes: a practical approach', IRL Press: Oxford, UK,
1990.
11
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32) Bernard, A.T. Archives of the Roum.De.Pathol.Exper. 1947, 14, 53.
33) Bangham, A.D. Hospital Practice 1992, Dec. 15th, 51.
34) Phillips, N.C. Bulletin of the Institute of Pasteur 1992, 90,205.
35) Finkelstein, M.; Weissman, G. Journal of Lipid Research 1978, 19,
289.
36) Leyland-Jones, B. Seminars on Oncology 1993, 2 0 ,12.
37) Chopra, R.; Goldstone, A.H.; Fielding, A. Leukemia and Lymphoma
1992, 7, 73.
38) Gray, A.; Morgan, J. Blood Reviews 1991, 5,258.
39) Skaiko, N.; Cajkova, M.; Jalsenjak, I. International Journal of
Pharmaceutics 1992, 8 5 ,97.
40) Strauss, G. Journal of the Society of Cosmetic Chemists 1989, 40, 51.
41) Williams, L.E.; Proffitt, R.T.L.L. Journal of Nucl.Med.Allied Science
1984, 28, 35.
42) Jones, M.N. Advances in Colloid and Interface Science 1995, 5 4 ,93.
43) Papahadjopoulos, D.E. Ann.N.Y.Acad.Sci. 1978, 308.
44) Szoka, F.; Olson, F.; Heath, T.; Vail, W.; Mathew, E.;
Papahadjopoulos, D. Biochimica et Biophysica Acta 1980, 601, 555.
45) Kolchens, S.; Ramaswami, V.; Birgenheier, J.; Nett, L.; O'Brien, D.F.
Chemistry and Physics of Lipids 1993, 6 5 ,1.
46) Van Zanten, J.H.; Monbouquette, H.G. Journal of Colloid and Interface
Science 1991, 146, 330.
47) Van Zanten, J.H.; Monbouquette, H.G. Journal of Colloid and Interface
Science 19 9 4 ,165,512.
48) Strawbridge, K.B.; Hallett, F.R. Macromolecules 1994,27,2283.
49) Dempsey, C.E. Biochimica et Bbphysica Acta 1990,1031,143.
50) Goldmann, W.H.; Senger, R.; Kaufmann, S.; Isenberg, G. FEBS Lett
1995, 368, 516.
51) Ohki, S.; Marcus, E.; Sukumaran, D.K.; Arnold, K. Bbchimba et
Bbphysba Acta 1994,1194,223.

12
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

52) Faucon, J.F.; Bonmatin, J.M.; Dufourcq, J.; Dufourc, E.J. Biochimica et
Bbphysica Acta 1995, 1234,235.
53) Lentz, B.R.; McIntyre, G.F.; Parks, D.J.; Yates, J.C.; Massenburg, D.
Bbchemistry 1992, 3 1 ,2643.
54) Fang, Y.; Dalgleish, D.G. Langmuir 1995,11, 75.
55) Strawbridge, K.B.; Palmer, L.R.; Merril, A.R.; Hallett, F.R. Bbphysbal
Journal 1995, 6 8 ,131.

13
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER 2
A VERSATILE INSTRUMENT FOR RAPID AND TIME-RESOLVED STATIC
LIGHT SCATTERING FROM POLYMER SOLUTIONS1

1This chapter is derived from the paper, “Static light scattering instrument
for rapid and time-resolved particle sizing in polymer and colloid solutions”,
Review of Scientific Instruments 67 (10), October 1996.
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2.1 INTRODUCTION
Static light scattering, SLS, is an analytical technique by which the
angular distribution of scattered intensity is collected from a polymer
solution. Because of its reliable and non-perturbing nature, the SLS
experiment has been employed in the study of a variety of biopolymer
problems.1'3 The key hardware component of conventional SLS
spectrometers is a photomultiplier tube attached to a revolving arm which
allows manual rotation about the horizontal plane of scattering. The task of
manually changing angles takes too much time and prevents the
observation of dynamical processes inside the sample. As a result, a
number of SLS instruments that feature automated data acquisition devices
have been built and some reviewed in the literature.4,5
Our instrument exploits a three lens focussing scheme coupled to an
intensified silicon diode array. The main feature is that we have tailored the
system to monitor dynamic processes in polymer solutions. The present
report offers a complete description of the apparatus and results of
calibrations performed with uniform polystyrene latex suspensions. We also
summarize data from one of the first applications of our machine: following
the interaction of Triton-X 100 with vesicle suspensions composed of
dimyristoylphosphatidylcholine.

2.2 DESIGN OF SLS INSTRUMENT
2.2.1 Description
Figure 2.1 shows a schematic of the basic components of the modified
SLS apparatus. The light source is a 5 mW He-Ne laser. The sample is
housed in a cylindrical copper chamber which is mounted onto a centering
device. Light scattered by the sample is directed through an optical system
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of three lenses and a diaphragm. The configuration chosen is that which
optimized the number of angles resolved by the detector.

detector axis

5 mW He-Ne laser

offset angle

sample
lens 1

lens 2
pinhole
lens 3
linear diode array

Figure 2.1 Schematic of key features of SLS instruments.
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incoming beam

sample
beam stop
\

(optional)

lens 1

lens 2
pinhole___
r~ /\

lens 3
OMA
Figure 2.2 Close-up of scattered beam path.
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We are using a model 1454 EG&G intensified detector with a 512-element,
silicon photodiode array. The whole assembly is mounted atop a Troyke
goniometer which permits rotation of the detection system about the
horizontal axis of the sample cell. This enables the selection of angular
windows forty consecutive degrees in range from -20 degrees to -120
degrees. The key is that parallel laser rays get focused to a point on the
detector. Figure 2.2 shows parallel nonaxial light emanating from within the
scattering volume at an angle 6 to the incident beam. After reducing the
incident light levels with neutral density filters, the laser may be directly
aimed at the array detector. By rotating the laser, it was found that each
pixel of the detector corresponds to 0.17702° of an angle (see Figure 2.3).
Such an arrangement also permitted determination of angular resolution. As
shown in Figure 2.4 the full angular width at half intensity of the laser at 0°
scattering angle was found to be 0.7208° (4 pixels). Insertion of a sample
(water) broadened the value to 1.2614° (7 pixels).

2.2.2 Principles of Operation
A brief explanation of how intensity measurements are made is provided
here. It is assumed that no light is lost due to absorption in the sample.
Also ignored are the variations in laser intensity and the use of filters to
reduce incident beam intensity. Light detected by the photodiode array
consists of the scattered intensity from the sample ( I ) which is of interest to
us, stray light (S ), background scattered light (B), and a dark signal (D). In
addition, the scattered intensity observed contains a geometry term, (g),
which must be determined for each detector element, or angle. This term
accounts for the volume that the detector “sees” at each angle along with
variations due to reflections, lens aberrations, and other instrumental flaws.
The equation below describes the measured signal (R):
18
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eq.1

R = g (l + B) + S + D

where all terms except g are measured per unit time. This is the master
equation and it applies to any scattering angle. By incorporating the
subscripts “s" (sample) and “bs” (blank) into the equation we obtain the
following expressions:

eq. 2

eq. 3

Sample: Rs = g( ls + B$) + S* + Ds

Blank:

Rte = g( 0 + Bto) +Ste + Dte

Subtraction of the measured blank signal from the measured sample signal
yields:
eq .4

R, - Ri* = gls + (S$ ■ Sbs) + (D$ - Dt«)

The geometry term is found by measuring the signal from a Rayleigh
standard. The same equations apply and by inserting the subscripts Y
(Rayleigh standard) and “br" (blank) we obtain:

eq. 5

Rr “ Rbr = glr + (Sr “ Sbr) + (Dr " Dbr)

Great care is taken to ensure that the stray light and dark signal are
negligible. Then, since lr is a constant of angle for a valid Rayleigh
standard, the geometry term can be computed. Absolute intensities are not
required for this type of experiment so a normalized “g” is computed by
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dividing the function glr through by its maximum value. To reference the
intensities to lr we divide equation 4 by equation 5:

400

350

300

TD 250

200
0.17702 degrees per pixel

150

100
•20

0

-10

10

20

Angle
Figure 2.3 Plot of instrument response to pixel vs angle
adjustment. Measurements were taken at 0° offset angle.
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Figure 2.4 Intensity peak of laser beam at 0° offset angle observed
before and after insertion of a sample (water). The effect was a slight
broadening of the linewidth.
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R . - R *

eq.6

Is

Rr-Rtr I

The validity of this appproximate form depends upon the suppression of the
stray light and dark count, if lr is set to unity the desired measurement of ls
can be obtained. The angular dependence of ls is well approximated by the
Guinier-Debye expression:

eq.7

lnls = lnl0- q2Rg2/3 +

note: q =

where ls is the intensity of scattered radiation, q is the magnitude of the
scattering vector, n is the refractive index, X is the laser wavelength in
vacuo, 0 is the scattering angle, and Rg is the radius of gyration. The
Guinier-Debye expression is used to obtain measurements of the radius of
gyration from plots of In I, versus q2.
2.3 EXPERIMENTAL METHODS

Uniform polystyrene latex microspheres (10% solids) of diameters 497
nm, 87 nm, and 173 nm were purchased from Duke Scientific Corporation.
A latex of diameter 297 nm was obtained from IDC Spheres. Sizes were
confirmed by dynamic light scattering. Latex/Water suspensions were
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prepared by adding 3 ml of dust-free water from a Barnstead Nanopure
purifier to one drop of the appropriate latex suspension.
The lipid dimyristoylphosphatidylcholine (DMPC) was purchased from
Sigma Chemicals. Chloroform and methanol were purchased from Aldrich
Chemicals. Triton-X 100 was purchased from Sigma. Vesicle suspensions
were prepared by the “Handshaken" method.6 In a 100-150 ml roundbottomed flask, 10 mg of the lipid was first dissolved in 2 ml of a
chloroform/methanol (2:1) solution. Removal of the solvent by rotary
evaporation resulted in the formation of a thin lipid film. The film was
allowed to dry in a vacuum oven overnight. A suspension of multilamellar
vesicles (MLVs) was prepared by hydrating the dried lipid film with 2.5 ml of
a 10 mM NaCI and 2.5 mM sodium phosphate buffer (pH = 7.4). Glass
beads were added to the flask and the container was vigorously shaken.
The MLVs were extruded through a 100 nm polycarbonate filter on a
Liposofast extrusion apparatus to obtain monodisperse suspensions of
vesicles with a diameter of 65-80 nm. The size was determined by both our
instrument and dynamic light scattering. Then 0.2 mM sample aliquots were
prepared by diluting the appropriate amount of stock solution with 3ml of
buffer. All suspensions were filtered through 0.2 pM Whatman (PVDF)
membranes before analysis. Triton was added at a 40:1 surfactant:lipid
ratio. A microemulsion composed of 9.1 ml H20 , 116 pi hexadecane, 302 pi
n-butanol, and 0.532 g Brij-96 was used as the Rayleigh standard.
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2.4 TESTING AND RESULTS
We calibrated the instrument with monodisperse latex suspensions of
known diameter. The sizes were first checked by dynamic light scattering to
ensure validity. Measurements performed at two different offset angles are
summarized in Table 2.1. At an offset angle of 27° only the 497 nm and
297 nm latexes could be measured. At the 90° offset angle latexes of
diameters 297 nm, 173 nm, and 87 nm could be measured. The criterion
used for these studies was that the modified SLS machine had to measure
the average radius of gyration accurately to within an error margin of five
percent.
The ability of the instrument to follow changes in the average radius of
gyration in real-time was demonstrated with a lipid/surfactant study. The
detector was programmed to begin data sampling immediately after addition
of Triton-X 100 to a DMPC suspension (see experimental methods for
sample details). The experiment was carried out at 25° Celsius and at an
offset angle of 90 degrees. Intensity data were collected at ten second
intervals. Figure 2.5 shows the plot obtained for Rg versus time. The
average radius of gyration increased from -65 nm to -250 nm for the DMPC
vesicles. This result was confirmed by dynamic light scattering.
2.5 CONCLUSIONS
A static light scattering instrument has successfully been adapted to
study dynamical behavior. Our study of a DMPC suspension treated with
Triton-X 100 showed that Rg increased 5 fold within a ten minute period.
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The dips in the plot are likely due to inadequate mixing. Future work
includes developing better stirring/mixing methodology and mechanics.

Table 2.1 Test measurements of polystyrene latex.

Offset angle, <j>(deg)

True Rga(nm)

Measured Rgb(nm)

27

208

201

27

115

120

90

112

115

90

63.5

65

90

33

34

90

10

11

a From dynamic light scattering, applying the factor 3/5)1Kappropriate for
uniform spheres, to the hydrodynamic radius.
Error estimated to be ± 5% for all measurements except for the 11 nm Rg
whose error was slightly higher.
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Figure 2.5 Plot of the radius of gyration, Rg, vs time for 0.2 mM
DMPC vesicles treated with 8 mM Triton-X 100.

26
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2.6 REFERENCES
1) Strawbridge, K.B.; Palmer, L.R.; Merril, A.R.; Hallett, F.R. Biophysical
Journal 1995, 6 8 ,131.
2) Haller, H.R.; Destor, C.; Canned, D.S. Review of Scientific Instruments
1983, 54, 973.
3) Huglin, M.B.Light Scattering from Polymer Solutions’, Academic Press:
New York, 1972.
4) Strawbridge, K.B.; Hallett, F.R.; Watton, J. Canadian Journal of Applied
Spectroscopy 1991, 36, 53.
5) Chu, B.; Zhou, Z.; Moser, H.O. Review of Scientific Instruments 1992,
63, 2954.
6) New, R.R.C.L/posomes: a practical approach’, IRL Press: Oxford, UK,
1990.

27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER 3
THE EFFECT OF TWO MODEL AMPHIPATHIC a-HELICAL PEPTIDES
ON DIOLEOYLPHOSPHATIDYLCHOLINE VESICLES: A LIGHT
SCATTERING STUDY
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3.1 INTRODUCTION
The previous chapter presented the design and fundamental principles
for a unique instrument capable of following polymer solution behavior in
real-time. Test experiments demonstrated its utility in monitoring the
changes in the radius of gyration, Rg, for a vesicle suspension treated with
Triton-X 100. In this chapter the technique, kinetic light scattering (KLS) will
be used to capture the dynamical trends in vesicle size that occur during
peptide/membrane interactions. A brief overview of the technique is
provided below but a more detailed explanation of the unique instrument
design is given in chapter 2 and elsewhere.1
Dynamic and static light scattering have already emerged as standard
techniques for characterizing the membrane disruption of phospholipid
vesicles.2'5 The usual application is to measure the average particle size of
the vesicles before and after addition of some membrane-active agent.
While this information is very valuable, the rate at which the interaction
occurs is also important, and often ignored. Non-specific turbidity
experiments are often used for such kinetic measurements.617 This chapter
will examine the particle size evolution of dioleoylphosphatidylcholine
(DOPC) vesicles treated with two model amphipathic a-helical peptides.
DOPC is a neutral phospholipid whose fluid phase extends to a very low
temperature of -18°C.
The study of vesicle/peptide interactions is important for elucidating the
mechanisms of lysis. Because of their amphipathic structure, it has been
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suggested8 that lytic peptides interact directly with and permeate the
membrane by the formation of concentration-dependent ion channels via a
‘barrel-stave’ mechanism (see Figure 3.1b). This mechanism involves three
steps: 1) binding of monomers to the membrane; 2) insertion into the
membrane to form a pore; and 3) progressive recruitment of monomer
peptide to increase the pore size. This is in marked contrast to data from
recent studies that suggest a ‘carpet-like’ mechanism.9 In this mechanism
the peptide: 1) binds parallel to the surface of and begins to cover the
membrane without much penetration; 2) self-associates once a critical
concentration has been reached; and 3) either through aggregation and/or
pore-like behavior creates defects in the lipid packing of the bilayer (see
Figure 3.1a).
Assessing the physical changes membranes undergo after disruption is
one of the major focal points of mechanistic studies.5 From a light
scattering perspective it is considered that the the action of a lytic peptide
may have one of the following effects on the vesicles (see Figure 3.2): 1)
the peptide could have no effect at all and the light scattering results would
return the same values before and after addition; 2) The peptide may cause
the fusion or aggregation of the membranes (3.2a and 3.2d). In this case the
light scattering data would return a size increase with the added possibility
of shape changes; 3) The peptide could completely obliterate the vesicle. In
this case the individual lipid molecules form small micellar structures (3.2b).
The light scattering data would show this as a drastic decrease in size if the
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signal is strong enough; and 4) The peptide could cause a slight swelling of
the vesicle due to partial insertion and/or adsorption onto the membrane
(3.2c). It should also be mentioned that the peptides may not interact with
all vesicles in the sample. This would lead to a polydisperse population of
affected and non-affected vesicles. Polydispersity can be detected with an
angle-dependent dynamic light scattering study. The problem is that shape
changes are also detected in this manner too.
Much research has gone into the design and subsequent synthesis of
model peptides that exhibit membrane activity.10*12 The peptides for these
experiments, (KLAKKLAh and (KLGKKLGh have been provided by
collaborators. Details of their design and synthesis appear elsewhere.13:14
Reported below are results of DLS and KLS experiments that examine the
effect of lipid-to-peptide ratio on the rate of interaction of the peptide/vesicle
suspensions. The data are analyzed for changes in the hydrodynamic radii
of the liposomes, rate of interaction, the diffusive character, and
polydispersity.

3.2 BACKGROUND
3.2.1 Dynamic Light Scattering
There are two types of laser light scattering: time averaged or static light
scattering and time dependent or dynamic light scattering. Quasi-elastic or
dynamic light scattering has become the standard method for the
measurement of diffusion coefficients for macromolecules. A typical
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Figure 3.1 Cartoon depictions of possible mechanisms of
action of lytic peptides: (a) peptide adsorbs onto surface of
bilayer (carpet mechanism); (b) peptide inserts into bilayer
(barrel-stave mechanism).
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(a) fusion

(c) swelling

Figure 3.2 Cartoon depictions of possible effects of peptides
on vesicles: (a) fusion; (b) micellization; (c) swelling; and (d)
aggregation.
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apparatus is shown in Figure 3.3. The key hardware components are a
laser source, optical system for harnessing scattered light (usually some
sort of lens train), detector, and signal analyzer. Under the usual conditions
of homodyne mixing and Gaussian statistics for the scattered field, the
experiment tracks the intensity autocorrelation function, the decay of which
is characterized by the particle diffusion coefficient. The correlation function
is given by:
G<2)( t)

= B(1 + f[g<1)(T)]2)

Where G(2)(t) is the second order intensity autocorrelation function, B is the
baseline, f is the coherence parameter (0<f<1), and g (1>(T) is the first order
electric field autocorrelation function. For translational diffusion in a
monodisperse solution, g(1>(x) can be expressed as a single exponential:
9(1,W = e 'r '

where r, the average decay rate, is related to the diffusion coefficient, D,
through the following relationship:

r = q2D
3.2.2 Static Light Scattering
In a static light scattering experiment the angular distribution of scattered
intensity, or the particle form factor P(6), is measured. The initial form of
P(0) provides a means for determining the mean square z average radius of
gyration. It is well approximated by the Guinier-Oebye relationship:
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Figure 3.3 Dynamic light scattering apparatus.
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where l(q) is the intensity of scattered radiation at scattering vector q (47insin(0/2)/Xo; n - solution refractive index, 6 = scattering angle, h> = laser
wavelength in vacuo), and Rg is the radius of gyration. From a plot of ln(l)
vs q2 an absolute measurement of Rg can be obtained.

3.2.3 Kinetic Light Scattering
The “kinetic" light scattering technique was inspired by the need for a
more thorough and accurate description of vesicle solutions undergoing
disruption by the action of a solubilizing agent. In addition, greater
efficiency of data acquisition was sought. The technique is similar to static
light scattering in that the scattered intensity of a sample is measured as a
function of angle to yield the root of the z-average of the squared radius of
gyration. The difference is that instead of measuring the scattered intensity
one angle at a time, an optical multichannel analyzer capable of detecting a
40 degree angle range instantaneously is implemented. The element of
kinetic analysis is incorporated through the use of data acquisition design
(DAD) software.
Figure 3.4 shows the general setup. See chapter2 fora more complete
description of the hardware and sampling protocol. In gist, an optical
multichannel analyzer (OMA) of 512 pixels records the scattered intensity
profile over a 40 degree angle range (Figure 3.5). This 40 degree range is
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defined by an offset angle or the angle that the rotating arm of the laser
makes with the 256th pixel (center) of the OMA. The intensity profile
obtained is then corrected for background scattering and geometry effects
(Figure 3.6). The background scattering is the underlying scattering from
the solvent matrix. The geometry factor describes the volume the detector
sees at a given scattering angle and also the light gathering efficiency of the
lens train and detector at different angles. It accounts for other effects too,
such as reflections. After the geometry correction and background
subtraction, Ln(l) vs q2 is plotted where the slope = - Rg2/3 (Figure 3.7).

Monitor

Lens 2

Lens 1

Lens 3

/

Laser
Sampe

Pinhole

Figure 3.4 General schematic for kinetic light scattering apparatus.
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Figure 3.5 Typical raw intensity profile for a vesicle
suspension, uncorrected for geometry and background.
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Figure 3.6 Intensity profile corrected for geometry and back
ground effects.

39
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

-2.90-

-2.95-

-3.00-

-3.06-

-3.10-

-3.1535
_ 2 /i

q/10 cm

Figure 3.7 Guinier plot for DMPC vesicles.
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3.3 EXPERIMENT
3.3.1 Materials
L-a-dioleoylphosphatidylcholine (DOPC) was purchased from Sigma
Chemicals in a rubber-capped chloroform solution, at concentration
20mg/ml and stored in the freezer at < 0°C. Additional chloroform was
purchased from Aldrich Chemicals. Sodium chloride(NaCI), and sodium
phosphate hepta hydrate (Na2HP0 4 .7H20) were purchased from EM
Sciences. The peptides, (KLAKKLAfe and (KLGKKLGh were obtained from
the peptide facility at Louisiana State University under the direction of Dr.
Mark McLaughlin.

3.3.2 Liposome Preparation
Vesicle suspensions were prepared by the “handshaken" method.15 Into
a 100-150 round-bottomed flask, 10 mg of the lipid was introduced using
disposable BD latex-free syringes and 23G1 needles. Additional chloroform
(1-2ml) was added via pipette to ensure a large enough volume for optimal
film formation. The flask was immediately covered with aluminum foil and
the chloroform was removed under a Buchler Instruments rotary evaporator
for 15-20 minutes. The resulting film was allowed to dry further overnight in
a Napco Model 5831 vacuum oven. The completely dry lipid film was
hydrated with 2.5 ml of a 2.5mM sodium phosphate, 10mM NaCI (pH = 7.47.5) to form a suspension of multilamellar vesicles (MLVs). The MLVs
were extruded 10 complete cycles through a 100 nm pore-size Avestin
polycarbonate filter on a Liposofast-Basic manual extrusion apparatus to
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obtain vesicles of uniform diameter 60 - 80 nm. Monodispersity was
validated by a multi-angle dynamic light scattering experiment. The data
are plotted in the form of r/q2 vs q2 to produce a curve, the flatness of which
is an indicator of polydispersity. All sample and stock solutions were
maintained by refrigeration at 5°C.

3.3.3 Peptide Solutions
The peptide resins, (KLAKKLAh and (KLGKKLGh, were obtained as
powders. Resins were typically 45-60% peptide by mass. Each was
dissolved in 1 ml of a 2.5mM sodium phosphate, 10mM NaCI buffer (pH =
7.4-7.5). The resulting solutions were passed through a 0.02 pm Anatop
“low-protein binding” filter and kept under refrigeration at 5° C.
In a control experiment, it was discovered that the manner in which the
peptide solutions are cleared of unwanted dust and debris affects the
resulting activity with vesicles. The peptide samples used in this control
study were approximately 4-5 yrs old and had been stored as solids in either
plastic (KLAKKLA)3 or glass (KLGKKLGh vials. The solid (KLGKKLGh
sample was "clumpy" and its solution was visibly cloudy. Given these
observations the experiments were performed with the intent of only
ascertaining whether filtering vs centrifuging makes a difference. No
inferences will be made as to why the specific effects in this study were
observed because the samples were obviously not ideal for serious scrutiny.
Both peptide solutions were made with a 2.5 mM phosphate, 10 mM NaCI
buffer, pH = 7.4-7.5. DOPC suspensions were prepared as above and
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treated with either centrifuged or filtered preparations of (KLAKKLA)3 and
(KLGKKLG)3 at a L:P molar ratio of 500:1. Measurements were taken using
DLS at a 45° scattering angle. Table 3.1 shows the "before and after”
results. (KLAKKLA)3 seemed to be the more sensitive. Centrifuging it
before addition to a DOPC suspension produced a 13% increase in size
while filtering it first produced a 20% increase in the average particle size. It
seemed here that filtration actually enhanced the peptide’s activity. The
results with (KLGKKLGfc contrasted greatly. A centrifuged (KLGKKLGh
essentially cleared the DOPC suspension while the filtered one had no
effect at all. Because the starting peptide solution in this case was cloudy it
is probable that it had aggregated and the process of filtering actually
removed it from the solution. The lesson from this experiment is that these
aged peptides behaved "differently” according to the method of choice for
cleaning the solutions. It is also demonstrated that the peptides can pass
filters if not aggregated. The extent to which previous experiments are
affected can not be gleaned, as the samples used in this study may not
have been in optimal condition. In those original experiments, however, the
solutions were clear. In future studies, the better method may be
centrifugation because at least with this one no question of sample loss or
activity due to passing through a membrane can be raised. It should be
pointed out that the protocol for all studies performed in this research used
the filtration method with the exception of all melittin experiments. In those
studies centrifugation was used.
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An alternative technique for conducting this control experiment would
have been UV absorption. In conversation with others in the research
cluster, it was learned that this particular experiment would not be ideal.
Because of very small extinction coefficients and unexplained sensitivities of
the peptides to the solution environment, early experiments performed
showed that the results obtained are essentially inconclusive.

Table 3.1 Results of OLS Control Study of Peptide Filtration Protocol

Rh of DOPC vesicles9 (nm)

Peptide

Alone in buffer

(KLAKKLA)3

73.1 ±1.8

(KLGKKLG)3

68.1 ±1.3

Centrifuged peptide
(500:1)
83.1 ±2.5

Filtered peptide
(500:1)
90.4 ±1.3

JO

69.8 ±1.3

a average of 5 runs using method ol cumulants
b decay signal too fast to measure

3.3.4 Preparation of Light Scattering Suspensions
Samples were prepared in dust-free environmental sample vials, 8 dram.
The vials were prepared using a cleansing protocol consisting of first
washing the vial with a small amount of Alconox cleanser and then rinsing
the vial repeatedly with ultra-pure water, final filter size 0.2 pm, until no dust
could be detected using the viewing lens on the light scattering apparatus.
The ultra-pure water source was a Barnstead Nanopure system fed by a
Millipore Milli-R/Q water purifier.
44
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Appropriate dilutions were prepared by adding filtered buffer solution to
aliquots of the lipid stock solution. The lipid-to-peptide ratios examined
were 1000:1,500:1,100:1,10:1, and 1:1. All vesicle suspensions were
filtered through a 0.2 pm Whatman polyvinylidene (PVDF) filter. An
appropriate amount of peptide, corresponding to the desired lipid-to-peptide
ratio, was then added to the vesicle suspension.

3.3.5 Methods
Kinetic light scattering measurements were performed using a 5 mW HeNe laser operating at Xo = 632.8 nm and at an offset angle of 90°. Data
sampling was controlled by a computer-driven optical multichannel analyzer
and intensity profiles were collected in 3 s intervals for 180 s each run.
Temperature control of the samples was achieved using a locally-made
water-jacketed cell holder connected to a Neslab circulating bath.
Dynamic light scattering measurements were made on a multiangle
machine at scattering angles of 20°, 45°, 60°, 90°, and 120°. The light
source was a Melles Griot He-Ne laser operating at 30 mW with maximum
output at 632.8nm. Scattered light was collected on a photomultiplier tube
and monitored by a Pacific Instruments laboratory photometer. Sample
runs were measured using an ALV-5000 multiple tau digital correlator.
Analyses were performed using the method of cumulants. The temperature
was maintained at 25 ± 0.1 °C for the duration of each experiment using a
Neslab water bath.
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3.4 RESULTS
3.4.1 Preliminary Findings
In preliminary light scattering studies, it was sought to determine the
gross response, if any, of DOPC vesicles to (KLAKKLAfc and (KLGKKLG)3.
Figures 3.8 and 3.9 show the superposition of 10 KLS intensity traces,
collected at 30 s intervals, for 0.2mM DOPC vesicles treated with 0.04mM
(KLGKKLG)3 and (KLAKKLAfe respectively. While a significant increase in
intensity is observed for vesicles treated with (KLAKKLAfe, no increase at all
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Figure 3.8 Superposition of intensity profiles from a 0.04mM
(KLGKKLG)3 and 0.2mM DOPC vesicle suspension.
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Figure 3.9 Superposition of intensity profiles taken from a 0.04mM
(KLAKKLAh and 0.2mM DOPC vesicle suspension.
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Figure 3.10 Plot of Rg vs time for 0.2mM DOPC vesicles treated with
0.04mM (KLAKKLA)3.
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was seen for those treated with (KLGKKLGK The average particle size of
the vesicles treated with (KLAKKLAfc increased from 65nm to ~80nm.
Those treated with (KLGKKLG)3 exhibited no change at all in the average
particle size. Because of the minimal response of (KLGKKLG) toward the
vesicle system using KLS, all further experiments in this chapter were
performed using (KLAKKLA)3 only.

3.4.2 Interaction of (KLAKKLAfo with DOPC using KLS
The plot obtained of Rg vs time, Figure 3.10, for the DOPC/(KLAKKLA)3
experiment revealed that the bulk of the interaction occurred in the first few
minutes as the average particle size stabilized within that period.
Subsequent measurements revealed that this average particle size was still
unchanged one week later. Hence the peptide concentration dependence
studies tracked only the first 180s of vesicle changes after addition of
(KLAKKLA)3 in order to extract the most meaningful information.
Experiments were performed with a lipid concentration of 0.3mM with the
exception of the 1:1 study where a concentration of 0.03mM lipid was used.
This was done in order to avoid using a concentration of (KLAKKLAhthat
would encourage aggregation of the peptide and also to avoid lipid
concentrations that would produce number fluctuations or other artifacts in
the light scattering.
The interaction was monitored immediately after addition of peptide to
the vesicle suspension. Sixty traces for each lipid-to-peptide ratio were
collected. All were individually analyzed for the value of Rgand plotted as a
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function of time. Figures 3.11-3.15 show the evolution of particle size for all
ratios. Each ratio was run twice. Visual inspection of the plots revealed a
possible mixing problem for the 100:1 and 1:1 ratios analyzed. A similar
occurrence of “dips” happened in the case of the DMPC/Triton experiment
in chapter 2. An improved systematic way of delivering the peptide to the
solution could probably solve this. Even so, the trend was still evident. For
all lipid-to-peptide ratios, a marked increase in Rg was observed. By
inspection it appeared that this fairly quick and steady increase exhibited
scaled linearly with time . At smaller concentrations of peptide, 1000:1 L:P
and 500:1 L:P, the increase in Rg was minimal, - 1.5-2nm, which is
analogous to results reported by Strawbridge et al who attributed the slight
change in size to vesicle swelling due to peptide binding.16 In the
experiment a light scattering instrument of different design but similar
capability was used to monitor the effect of the channel-forming colicin E1
peptide on 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC)
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol (POPG)
vesicles. Studies of magainins and alamethicin have revealed a
concentration dependent orientation and hence activity of the peptides.17 At
low concentrations it is hypothesized that the peptide is surface bound. At
high concentrations a more “inserted” type of orientation leads to
subsequent disruption. This could also account for a slight increase in Rgin
these experiments if the lipid packing is affected enough to detect. At
higher concentrations of peptide a more significant increase in Rg was
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observed, the more dramatic one occurring at the 100:1 L:P ratio. Two
possible explanations for this increase exist. The increase, from ~ 70nm to
>100nm, could possibly be explained by vesicle fusion. The other
interpretation of the increase could be aggregation. Finally, as can been
seen in Figure 3.16, a comparison of rates (obtained using a linear
regression routine in Microcal Origin) from the L:P experiments at various
L:P ratios showed a general upward trend with increasing concentration of
peptide.

3.4.3 Interaction of (KLAKKLAfo with DOPC using DLS
To obtain more insight into the interaction of the peptide with DOPC
vesicles, the effect of (KLAKKLA)3 on the hydrodynamic size, Rh, the mutual
diffusion coefficient, Dm, and the size distribution of the vesicle suspensions
was examined by dynamic light scattering. The same concentrations and
sample volumes as in the KLS study were used. All experiments were
performed from the same lipid and peptide stock solutions. For all DLS
experiments vesicle suspensions were measured at 5 different angles
before and after peptide addition. The “after” measurement was taken at a
5 minute “incubation” limit.
Table 3.2 shows the general changes in Rhfor each L:P ratio before and
after peptide addition. Values were taken from 60° data. In all cases, a
third-order polynomial fit to the correlation functions, using ALV-5000
software, was applied to extract Rh using the cumulants method. Once
again, there was a trend toward greater changes in the average particle size
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Figure 3.11 Plot of Rg vs time for 1000:1 L:P ratio.
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Figure 3.12 Plot of Rg vs time for 500:1 L:P ratio.
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Figure 3.13 Plot of Rgvs time for 100:1 L:P ratio.
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Figure 3.14 Plot of Rg vs time for 10:1 L:P ratio.
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Figure 3.15 Plot of Rg vs time for 1:1 L:P ratio.
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Figure 3.16 Rate comparison for all L:P ratios.

57
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1000

at higher concentrations of peptide. The DLS data did not show as big of an
increase in size for the 100:1 L:P ratio which was 38% less than the KLS
result. The most significant percent increases occurred at the 1:1 (-17%)
and 10:1 (-26.1%) L:P ratios. Similar changes were seen by KLS at the
same ratios, -24% and -19% respectively. The gross effects observed are
consistent with earlier findings: mild increases in the average size at low
concentrations of peptide and relatively larger increases in the average size
at higher concentrations of peptide.
Additional information is available from the angular dependence of the
DLS measurements. For all L:P ratios a master plot of the apparent
diffusion coefficient (Dw ) vs the squared wave vector (q2) was obtained to
illustrate how diffusion in these systems was affected. Figure 3.17 shows a
decreasing trend in Dw with increasing concentration of peptide. This
occurred with a significant positive change in slope for larger concentrations
of peptide. This observation usually signals the presence of polydispersity
which was also evidenced by the broadening in the particle size distributions
discussed ahead. At the lower concentrations this result could be
rationalized as distributing of the peptide among the population of vesicles
and/or with the occasional formation of aggregated or fused vesicles. At the
higher concentrations of peptide it is possible that the peptide induces a
more distinct heterogenous population that includes fused/aggregated
vesicles coexisting alongside the original structures. Another possible
explanation for the positive change in slope would be a change in shape as
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DLS is sensitive to the geometry of the particle. Figure 3.18 elaborates
further on the polydispersity issue. The parameter “C", whose value is
obtained from the following equation,
Oapp = Do(1 + Cq2)
is associated with polydispersity and/or a shape change. It is plotted as a
function of L:P ratio. A marker to the far right of the plot shows C for a
uniform vesicle suspension. There is a marked increase in C toward higher
concentrations of peptide indicated by the data.
For the same 60° data, the particle size distributions were obtained using
CONTIN. Figures 3.19-3.23 show the changes in the distribution of Rh
before and after addition of (KLAKKLAh. The results revealed a definite
trend toward broadening of the distribution with increasing concentration of
peptide. The 1:1 data, however, were perplexing as, although the average
size increased, the change in Rh was very sharp with little broadening. At
other ratios, e.g. 100:1 and 10:1, evidence of broadening is much more
striking, especially in the high Rh region. Intensity increases at the lower
scattering angles also indicated size changes, hence polydispersity. For
example, at a L:P ratio of 10:1 the intensity increased 75% at 20°, 57% at
45°, and 31% at 60°.
The case presented for polydispersity, although reasonable, may not be
sufficient evidence alone. The changes in the average size observed can
also be explained by alterations in shape. The magnitude of scattering from
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any one component in a DLS sample depends in part upon the particle
structure factor, P(6), which describes the angular dependence of scattering
for larger particles. It could be speculated that the vesicles, whose
structures are not rigidly spherical, may bend or contort in solution and/or
may do so in the presence of peptide. This is probably not a significant
factor in this case because given the experimental range of sizes and the
chosen scattering angle of observation,.measurements probably remain in
the realm of pure translational diffusion. This point is discussed further
below.
3.5 CONCLUSIONS
The physical characteristics of DOPC vesicle suspensions treated with
the model peptide (KLAKKLAfe were investigated at 5 lipid-to-peptide ratios
and monitored with respect to average changes in Rg, Rh, and the particle
size distribution. In addition, these changes were strictly monitored with
time-evolution experiments using a novel twist to the conventional light
scattering treatment.
Overall the trend was clear: DOPC vesicles are clearly vulnerable to the
activity of (KLAKKLAfe. The average changes seen in both KLS and DLS
indicate that the general effect is an increase in the average particle size of
the vesicle. This general increase becomes more pronounced at higher
concentrations of peptide. The more profound interactions occurred at
100:1 and 10:1 L:P ratios. Smaller increases/perturbations could be
explained by swelling due to adsorption onto the surface. Fusion or
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aggregation of the vesicles may be probable causes of the larger changes.
A viewpoint, borrowed from a concentration-dependent mechanism,
describes the formation of surface-bound peptide/vesicle complexes at low
concentrations of peptide and the formation of highly altered vesicles at high
concentrations of peptide due to induced defects in membrane packing.
This is the most likely mechanism. Angle-dependent DLS data further
suggest that the resulting suspension is heterogenous, being comprised of
aggregated/fused vesicles and the original structures. A less likely factor
would be possible shape changes in the vesicles as this could also affect
the resulting particle size and diffusion data. In DLS there is also the
limitation that the experiment is only valid so long as qRh«1 • To stay within
the boundaries of theory, the value of qRh, a measure of the spatial
frequency, must satisfy the requirement qRg « 1 where Rg and Rh are
related according to the geometry of the particle. In this regime, only the
overall translational motion of the particle is seen. AtqRh» 1 the internal
motions within the particle contribute to the signal. These would include
changes in shape. The qRh values for these experiments ranged from 0.81.4.
The model peptide (KLGKKLGfowas not a good candidate for these
studies using the chosen techniques and experimental conditions. Its
minimal behavior with neutral membranes has been explained in terms of
both helicity and charge by Javadpour ef a/.13 (KLGKKLG)3 has a relatively
low helical content in sodium dodecylsulfate (SDS) micelles and
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dilaurylphosphatidylcholine (DLPC) vesicles (L:P = 30:1). a-Helicity is a
known prerequisite for lytic activity. Also antimicrobial peptides display
selectivity by inhibiting or killing bacteria without showing toxicity toward
mammalian cells. Bacterial cell membranes are negatively charged while
mammalian cell membranes are neutral. DOPC is a neutral lipid and
consequently does not encourage the action of the positively charged
(KLGKKLG)3. Both peptides show higher a-helicity in negatively charged
vesicles than in neutral ones.

Table 3.2 Average Rh values for DOPC vesicles treated with varying
amounts of (KLAKKLA)3 before and after addition of peptide.

L:P Ratio

Rhbefore (KLAKKLA)3a

Rh after (KLAKKLA)3a

% Change

1000:1

62.0 ± 0.8 nm

62.0 ± 0.6 nm

500:1

56.0 ± 0.5 nm

62.3 ± 0.5 nm

10.1

100:1

61.3 ±0.6 nm

69.4 ± 0.3 nm

11.7

10:1

54.8 ± 0.7nm

74.2 ± 0.7 nm

26.1

1:1

58.7 ± 0.5 nm

71.0 ±0.5 nm

17.3

aaverages calculated on 5 runs using ALV software
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Figure 3.19 Particle size distribution of 1000:1 DOPC/(KLAKKLA)3
suspension before and after peptide addition.
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Figure 3.20 Particle size distribution of 500:1 DOPC/(KLAKKLA)3
suspension before and after peptide addition.
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Figure 3.21 Particle size distribution of 100:1 DOPC/(KLAKKLA)3
suspension.
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Figure 3.22 Particle size distribution of 10:1 DOPC/(KLAKKLA)3
suspension.
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Figure 3.23 Particle size distribution of 1:1 DOPC/(KLAKKLA)3
suspension.
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CHAPTER 4
MONITORING PEPTIDE/MEMBRANE INTERACTIONS WITH
FLUORESCENCE PHOTOBLEACHING RECOVERY
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4.1 INTRODUCTION
Peptide/membrane interactions have been explored by a variety of
experimental techniques in order to gauge one or more of the essential
aspects of cell disruption.1'5 Of particular interest to present studies is the
effect that the peptide has on the resulting membrane morphology of the
lipid system. Dynamic light scattering (DLS) has been widely used to
monitor the physical properties of vesicle systems.6 In the previous chapter
dynamic light scattering and static light scattering studies assessed how
DOPC lipid suspensions were affected by the model peptide (KLAKKLA)3 at
different concentrations. In principle, DLS measures the rate of diffusion of
suspended particles and is sensitive to almost any particle whose size lies
between 1 and 1500 nm. In solutions of particles of various sizes this
sensitivity is dominated by the larger particles present as they scatter more
strongly, especially at smaller angles. Also, at large qR, DLS becomes
sensitive to internal motions, such as undulating surface distortions of
vesicles.
Fluorescence photobleaching recovery (FPR) has already become a
popular tool for probing the lateral diffusion of lipids and proteins in artificial
and biological membranes.7*11 The potential to measure the translational
diffusion of liposomes themselves has not yet been fully exploited by the
technique. Like DLS, FPR measures the rates of diffusion of suspended
particles. The measurement is different as it can be used to measure the
diffusivities of fluorescently labeled particles of practically any size typically
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found in suspensions. In DLS the scattering intensity depends in part on the
particle form factor P(0) which varies according to the size and shape of the
particle. This dependency is not present in FPR because it operates over a
longer distance scale (27t/K as compared to 27t/q in DLS) and is therefore
not sensitive to intraparticle changes. One note of caution is that the
temperature sensitivity of the vesicles must be taken into account when
choosing the photobleaching conditions. This is addressed in the chapter
with control experiments.
The objective in this study was to first establish the efficacy of FPR as a
viable technique to follow the diffusion of labeled dioleoylphosphatidylcholine (DOPC) liposomes in aqueous solution. DOPC was chosen
because of its availability, cost-effectiveness, and low phase transition
temperature. It also serves as a good model for eukaryotic cells which is of
importance for biophysical studies. Addition of Triton-X 100 to DOPC lipid
suspensions was observed to show how FPR could monitor particle size
changes. The interaction of Triton-X 100 with phosphatidylcholine vesicles
has already been widely investigated by many techniques. It is generally
accepted that Triton-X 100 disrupts the vesicle bilayer leading to the
formation of lipid-detergent mixed micelles.
The second objective of this study was to continue the characterization
of the interaction of the two model amphipathic a-helica! peptides,
(KLAKKLAh and (KLGKKLGh with model cell membranes. For these
experiments, neutral and negatively charged vesicles were used as models
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for eukaryotic and prokaryotic cells, respectively. The interaction was
studied using fluorescence photobleaching recovery (FPR) and dynamic
light scattering (DLS). Vesicle diffusion before and after addition of peptide
was measured as a function of lipid-to-peptide (L:P) ratio and composition of
the lipid bilayer. A melittin study for the same vesicle systems was also
undertaken for comparison.
4.2 BACKGROUND
The dynamic light scattering technique and instrument are explained in
Chapter 3.
Fluorescence photobleaching recovery is based on the principle of
observing the rate of recovery of fluorescence due to the movement of a
fluorescent particle into an area of the sample that contains the same
particle but that has been rendered nonfluorescent via an intense
photobleaching pulse of laser light. The rate of recovery is related to the
diffusion coefficient of the particle. More specifically, a striped pattern is
created by illuminating a coarse diffraction grating (Ronchi ruling) held in the
rear image plane of a standard epifluorescence microscope with an intense,
brief laser flash. With the laser intensity greatly attenuated, an
electromechanical modulation detector system similar to that of Lanni and
Ware monitors the subsequent disappearance of the pattern due to
exchange of molecules that were bleached and those that were not.12 The
ac amplitude from the modulation detector decays exponentially where:
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ac(t) = exp(-K2Dst)
and

L is the distance between stripes in the sample, and Ds is the tracer self
diffusion coefficient of the fluorescently labeled particle. A diagram of key
components is shown in Figure 4.1.

4.3 EXPERIMENTAL SECTION
4.3.1 Materials
The lipid dioleoylphosphatidylcholine (DOPC), dissolved in chloroform at
20 mg/ml, and Triton-X 100 were purchased from Sigma Chemicals. The
lipid dioleoylphosphatidylglycerol (DOPG) was purchased from Avanti Polar
Lipids in a chloroform solution with concentration 10mg/ml. The labeled
phospho-lipid NBD-C12-HPC (2-(12-(7-nitrobenz-2-oxa-1,3-diazol-4yl)amino)dodeca-noyl-1-hexadecanoyl-sn-glycero-3-phospho-choline) was
purchased from Molecular Probes. Chloroform was purchased from Aldrich
Chemicals. Sodium chloride (NaCI) and sodium phosphate hepta hydrate
(Na2HP04.7H20) were purchased from EM Sciences. The peptides
(KLAKKLA)3 and (KLGKKLGh were designed and synthesized in the
peptide facility at Louisiana State University under the direction of Dr. Mark
McLaughlin. Melittin was purchased from Sigma (70 % by HPLC) without
further purification.
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4.3.2 Preparation of Labeled Liposome Samples
Liposomes were prepared by the “handshaken" method. Details are
given in chapter 3. The lipids were mixed at a ratio of 4:1 DOPC/DOPG and
5 wt% nbd-HPC to make fluorescent, negatively charged liposomes. For
fluorescent, neutral liposomes, 5 wt% was mixed with DOPC. Aliquots of
the lipid stock suspensions were passed through a 0.2 pm PVDF filter
before usage. Samples with appropriate peptide concentrations and lipid
composition were prepared in 1 dram environmental glass vials (Fischer
Scientific) at the appropriate ratios and allowed to incubate for 5 minutes.

4.3.2.1 FPR Samples
A representative aliquot from each DLS vesicle suspension described
below was extracted using a Vitrodynamics microslide, inner dimensions 0.2
mm x 0.4mm. The ends were flame-sealed. The microslide was held at 25
±0.1 °C during measurements.

4.3.2.2 DLS Samples
The samples for dynamic light scattering required more care in their
preparation because of the sensitivity of the measurement to dust and other
artifacts. Cleanliness of the sample cell was a high priority. Sample cells
were prepared in a similar method to that described in chapter 3.
Appropriate amounts of lipid and peptide were added at ratios of 500:1 and
1:1 L:P. An incubation period of 5 minutes was allowed after which the
measurements were made. Melittin-treated samples were allowed to
incubate 20 minutes. As already discussed in chapter 1, the peptide venom
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melittin is known to induce morphological changes in the bilayers of
phosphatidylcholine vesicles causing distinct alterations in membrane
properties.

4.3.3 Peptide Solutions
Peptide resins were obtained from the LSU peptide facility in glass vials
as powders. According to usage, the needed amounts were dissolved in a
2.5 mM phosphate/10 mM NaCI buffer (pH = 7.48) and stored in 1 dram
environmental glass vials. All peptide solutions were stored at < 5 °C.
Melittin (70% by HPLC) was purchased from Sigma Chemicals. As
needed, specified amounts were dissolved in a 2.5 mM phosphate/10 mM
NaCI buffer (pH = 7.48) and stored in 1 dram environmental glass vials. All
melittin solutions were stored at < 5 °C.

4.3.4 Methods
4.3.4.1 Light Scattering Data Acquisition
Multi-angle measurements of both lipid systems alone, DOPC and
DOPC/DOPG, were performed at scattering angles of 30,45,60,90, and
110 degrees to ensure uniformity. All before/after peptide experiments were
performed at 0 = 45°. Data were acquired as five 60 second runs which
were analyzed using the method of cumulants.

4.3.4.2 FPR Data Acquisition
All measurements were performed at one K value using a 10X objective
and a diffraction grating of 100 lines per inch. Data acquisition time varied
from 50 seconds to 600 seconds and all measurements were repeated at
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least 3 times. The data were fit with one exponential using ANSCAN, an
analysis package developed for FPR studies.

4.4 RESULTS
4.4.1 Sensitivity to Laser Exposure
The structure and fluidity of lipidic bilayers exhibit a well-documented
temperature dependence.13 Below a characteristic temperature, TCl the
phase transition temperature, the liposome bilayer exists as a tightly
ordered gel phase. As the temperature is raised above Tc, the bilayer
passes into a more fluid state where freedom of motion of individual chains
is higher. Because the liposomes used in these studies exhibit this
temperature sensitivity, it was necessary to assess their response to laser
power levels and bleaching pulses. It has already been shown that the
release of encapsulated dye from dipalmitoylphosphatidyl-choline (DPPC)
and dipalmitoylphosphatidyl-glycerol (DPPG) vesicles can be modulated by
laser exposure.14
Two experiments were performed, one in which two laser powers were
used and another where the effect of varying the bleach time was
monitored. Measurements were compared to a DLS result for the same
vesicle suspension. The bleach times examined were 0.5 seconds, 3
seconds, and 6 seconds.
The lipid DOPC was used for the study (see chapter 3 for sample
preparation). Measurement conditions were the same as described in
section 4.3. In the first experiment, three FPR traces were collected and
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averaged at two different power levels. At the lower power level (1,1W)
vesicle diffusion remained basically unchanged. Upon increasing the power
to 1.8W the presence of two diffusive modes was detected.
In the second experiment, the lipid sample was exposed to three
different bleach times (Figure 4.2). The shortest time, 0.5 seconds, proved
to match closest to the unbleached (DLS) sample. Based upon these
findings reported experiments were performed using bleach times of 1
second or less and at a laser power of ~ 1.1W.

Table 4.1 Effect of laser power exposure on DOPC vesicle

Power
(1.1 watts)
(1.8 watts)

Diffusion (cnrf/s) (FPR)
3.4x1 O'0
2 modes,
4.39x1 O'8 & 5.6x10-®

Diffusion (cntfs) (DLS)
3.6x10-°
3.6x10-°

4.4.2 Preliminary FPR/DLS Measurement Comparison
These results concern the simultaneous experiments conducted with
neutral DOPC vesicles with FPR and DLS to compare measurements. A
plot of the apparent diffusion coefficient Dw vs q2 is shown in Figure 4.3.
The Dw value obtained from the FPR experiment, shown also, was 15%
higher. This amounts to a difference of 20% between an Rh(DLS) and an
Rh(FPR) measurement for the same lipid system. It is not clear why this

occurred as other experiments not performed simultaneously produced
closer agreement.
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Figure 4.2 Histogram of DOPC vesicle diffusion at 3 bleach times.
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The sample used was a 0.3 mM DOPC vesicle suspension.

83
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4.4.3 DOPC/Triton-X 100 Experiment
It was necessary to test the FPR technique to see if gross changes in
lipid vesicles could be seen. In this experiment FPR recovery traces were
obtained for DOPC vesicle suspensions before and after addition of 10%
Triton-X 100. Before addition of Triton-X 100 the vesicles exhibited a
hydrodynamic radius of 65 nm. After treatment with the surfactant and a 5
minute incubation period the recovery time decreased sharply indicating the
presence of small diffusers. This result was similar to experiments
performed with DLS and is consistent with literature findings.15

4.4.4 DOPC, DOPC/DOPG (KLAKKLA)a and (KLGKKLG) Experiments
Changes in vesicle structure for DOPC and DOPC/DOPG suspensions
induced by (KLAKKLAh and (KLGKKLGh were assessed at high and low
peptide concentrations. All results are tabulated in Tables 4.2 and 4.3. At
low concentrations of (KLAKKLA)3 (500:1) the DLS result for DOPC vesicles
is similar to the one found previously in Chapter 3. A modest increase in the
hydrodynamic radius, ~ 10% is observed. The same measurement with
FPR showed no change in the average particle dimensions once the error is
considered. For DOPC/DOPG vesicles at a low concentration of
(KLAKKLA)3 , (500:1 L:P), DLS and FPR detected decreases of 3.7% and
9.2 % respectively. At high concentrations of (KLAKKLAfo (1:1 L:P) the DLS
result for DOPC vesicles showed an 11% increase in Rh which was
significantly lower than previously reported in chapter 3 (-20%). The FPR
measurement showed a reduction (18.5%). The peptide’s interaction with
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Table 4.2 Hydrodynamic radii for DOPC vesicles treated with
(KLAKKLA)3 and (KLGKKLG)3 by DLS and FPR.

Rn(nm) for DOPC vesicles
By DLS*

Rn (nm) for DOPC vesicles
By FPRb
(app. %changes In paranthasas)

(app. %changes In paranthaaea)

(L:P 500:1)

(L:P 1:1)

(L:P 500:1)

(L:P 1:1)

(KLAKKLA)3

(KLAKKLA)s

(KLAKKLA)s

(KLAKKLA)3

74 ±1.2
(10.4 %)

73 ±0.1
(11.4%)

60.5 ±1.9
(no change)

54.2 ±1.7
(-18.5%)

(KLGKKLGb

(KLGKKLGh

(KLGKKLG)3

(KLGKKLG)3

69.4 ±0.9
(3.2 %)

68.2 ±1.7
(16.6 %)

62.5 ± 5.8
(no change)

98.1 ±12.7
(32 %)

a average of five runs analyzed by cumulants
b average of three runs analyzed by ANSCAN

85

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 4.3 Hydrodynamic radii for DOPC/DOPG vesicles treated with
(KLAKKLA)3 and (KLGKKLG)3 by DLS and FPR.

Rh(nm) DOPC/DOPG vesicles
By DLS

Rn (nm) for DOPC/DOPG vesicles
By FPR
(app. %changaaIn parantfiaaaa)

(app. %changaaIn parantfiaaaa)

(L:P 500:1)

(L:P 1:1)

(L:P 500:1)

(L:P 1:1)

(KLAKKLA)3

(KLAKKLA)3

(KLAKKLA)3

(KLAKKLA)3

56.8 ±1.2
47.7 ±2.2
(-3.7 %)
(-26.5%)
(KLGKKLG)3 (KLGKKLG)3

41.7 ±0.8
(-9.2%)
(KLGKKLG)3

43.3 ±0.9
( no change)
(KLGKKLG)3

c

58 ±0.5
41.8 ±1
(3.4 %)
(-9.1 %)
aaverage of 5 runs analyzed by cumulants
baverage of 3 runs analyzed by ANSCAN
0 particles too big to measure

5
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DOPC/DOPG vesicles at high concentrations produced a reduction in Rh
(-25%) by DLS but the FPR compliment revealed no change.
At low concentrations of (KLGKKLGh (500:1L:P) a slight increase (3.2%)
was detected by DLS while FPR saw basically no change. At high
concentrations of the peptide the DOPC vesicles experienced an increase
of at least 15% by DLS. The amount is more if calculated by FPR (32%).
For both techniques the measurements from both DLS and FPR for
DOPC/DOPG vesicles were unattainable because of the formation of huge
clusters.

4.4.5 Melittin Results
The same experiments were also performed using melittin. The results of
the changes in size of DOPC and DOPC/DOPG vesicles with high/low
concentrations of melittin are shown are shown in Table 4.4. Intensities at
the high concentration are also listed. At the low concentration of melittin,
slight changes were seen by both techniques for both lipid suspensions. At
the high concentration of melittin, a drastic decrease in intensity was seen
by DLS for both lipid suspensions which was accompanied by a shift toward
foster decay rates. This combination of events made a complete analysis
too difficult to undertake, although it is probable that a size decrease
occurred because of the foster decay after addition of melittin. Likewise
corresponding analyses of FPR traces were also challenging because the
photobleaching constraints discussed in Section 4.4.1 coupled with the low
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Figure 4.4 Typical FPR trace for DOPC vesicles.
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dye content in the vesicles produced noisy data. Approximate sizes,
however, were calculated. Before and after FPR traces for DOPC vesicles
treated with a high (1:1 L:P) concentration of melittin are shown in Figures
4.4 and 4.5.
These results are consistent with previous reports. It has already been
established that the action of melittin at high concentrations leads to the
formation of micellar structures.16 At low concentrations slight changes in
vesicle size are well documented and are attributed to the perturbations due
to the initial adsorption of melittin onto the lipid membrane. These results
have been confirmed for both neutral phosphatidylcholine (PC) and
phosphatidylserine (PS) vesicles.17
4.5

CONCLUSIONS

This present study used DLS and FPR to examine the membrane
integrity of DOPC and DOPC/DOPG vesicle suspensions before and after
addition of the peptides (KLAKKLAh and (KLGKKLGh. In neutral DOPC
suspensions (KLAKKLAfe induced an increase in Rn at both concentrations
in experiments by DLS. The peptide showed no activity at all in the FPR
complement at the low concentration (500:1 L:P) ratio and a decrease of
(18.5%) at the high concentration (1:1 L:P) ratio.
At the low concentration of (KLGKKLGha small increase was detected
by DLS for DOPC vesicles that was not seen by FPR. At a high
concentration of (KLGKKLGh the two measurements seemed to both agree
that an increase of at least 10% took place in the average particle
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Table 4.4 Rh values for DOPC and DOPC/DOPG vesicles treated with
melittin : (a) by DLS; (b) by FPR; intensities from DLS for 1:1 experiments
notated in brackets.

(a)

Rh(nm) vesicles by DLSa
Lipid

Alone

w/Melittin 1:1

w/Melittin 500:1

_0

71.2 ±2.5

DOPC

69.2 + 0.7
[1 kHz]
[18 kHz]
_b
DOPC/DOPG
59.3 ±1
[2 kHz]
[22 kHz]
a average of five runs using method of cumulants
bdata insufficient for cumulant analysis

58.7 ±0.9

(b)

Rh(nm) vesicles by FPRa
Lipid

Alone

w/Melittin 1:1

w/Melittin 500:1

DOPC

55.2 ±1

3.1 ±0.5

53.0 ±4.4

DOPC/DOPG

37.8 ±7.1

3.44 ±0.4

33.7 ±2.7

a average of three runs analyzed by ANSCAN
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dimensions of the DOPC suspension. The higher increase was seen by
FPR (32%).
In the negatively charged suspensions of DOPC/DOPG at a low
concentration of (KLGKKLGk there was a small increase by DLS (3.4%) but
a significant decrease by FPR (9.1%). At a higher concentration,
(KLGKKLGh induced the formation of structures too large to measure by
either technique. Under a microscope the complexes formed were bright
clusters. The dimensions varied in size. The effect of (KLAKKLAb at a
higher concentration was perplexing because by DLS the average size of Rh
dropped while the FPR measurement remained essentially unchanged.
With regard to the presence of polydispersity suggested by the dynamic
light scattering experiment, the complement FPR analyses did not confirm
this. All traces exhibited vesicle diffusion that remained essentially
monoexponential, hence monodisperse before and after peptide addition.
This observation would support the argument that shape changes may be
occurring. See Figure 3.2 for a review of all possibilties. Quantitatively the
two techniques did not consistently agree; the FPR data showing the
greater amount of error. The FPR results would have produced better
agreement given quieter data, which would especially help in those
experiments where small changes occurred.
In general, the interaction of the peptides with neutral vesicles led to
increases in the average particle dimensions while decreases were seen
with negatively charged vesicles. This is probably due, in part, to enhanced
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electrostatic interactions in the negatively charged vesicle suspensions.
Another factor in all results may lie in the role of the buffer. In conversations
with Dr. Frederick Enright and Dr. Kathleen Morden, both members of the
research cluster, it was learned that the use of phosphate buffers with the
peptides studied sometimes produces ambiguous results. HEPES (N-(2hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) was suggested as a
better alternative.
4.6 FUTURE WORK
The interaction of two model peptides and with neutral and negatively
charged membranes has been investigated using two hydrodynamic
techniques, DLS and FPR. The resulting morphology was quantified and
discussed in terms of the average particle dimensions. The morphology can
also be observed directly using freeze fracture microscopy. This experiment
could provide more information about the shape of peptide/lipid complexes.
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